Ieq Capital LLC Purchases 122,282 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Ieq Capital LLC grew its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 764.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 138,276 shares of the company’s stock after purchasing an additional 122,282 shares during the period. Ieq Capital LLC’s holdings in Bath & Body Works were worth $5,361,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC boosted its holdings in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after acquiring an additional 324 shares during the period. TD Private Client Wealth LLC boosted its holdings in Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the period. UMB Bank n.a. boosted its holdings in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the period. Avior Wealth Management LLC boosted its holdings in Bath & Body Works by 30.3% during the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock valued at $76,000 after acquiring an additional 453 shares during the period. Finally, Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the 4th quarter valued at about $26,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $38.51 on Friday. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99. The firm has a market capitalization of $8.34 billion, a P/E ratio of 9.39, a P/E/G ratio of 0.95 and a beta of 1.83. The stock has a 50 day moving average price of $37.70 and a 200-day moving average price of $33.86.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the company earned $0.48 EPS. The business’s revenue was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Analyst Ratings Changes

BBWI has been the subject of several analyst reports. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $42.00 to $48.00 in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their target price on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley dropped their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Argus reiterated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Barclays increased their price objective on Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $43.63.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.